Stocks and Investing
Stocks and Investing
Fri, November 2, 2018
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
[ Fri, Nov 02nd 2018
] - WOPRAI
Edward Nash Downgraded (ADVM) to Hold on, Nov 2nd, 2018
Edward Nash of SunTrust Robinson Humphrey, Downgraded "Adverum Biotechnologies, Inc." (ADVM) to Hold on, Nov 2nd, 2018.
Edward has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Alethia Young of "Cantor Fitzgerald" Initiated at Buy and Held Target at $120 on, Friday, September 21st, 2018